We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVA icon
1801
DaVita
DVA
$12B
$53.7K ﹤0.01%
403
+116
+40% +$15.9K
TRNO icon
1802
Terreno Realty
TRNO
$7.4B
$53.5K ﹤0.01%
942
-294
-24% -$16.7K
LTH icon
1803
Life Time Group Holdings
LTH
$10B
$53.4K ﹤0.01%
+1,936
New +$55.2K
YUMC icon
1804
Yum China
YUMC
$16.3B
$53.4K ﹤0.01%
1,244
+920
+284% +$41.8K
SD icon
1805
SandRidge Energy
SD
$494M
$53.3K ﹤0.01%
4,725
+4,585
+3,275% +$50.6K
ARWR icon
1806
Arrowhead Research
ARWR
$12.7B
$53.3K ﹤0.01%
+1,545
New +$34K
SITC icon
1807
SITE Centers
SITC
$172M
$53.1K ﹤0.01%
+5,889
New +$62.6K
ETHA
1808
iShares Ethereum Trust ETF
ETHA
$5.48B
$52.9K ﹤0.01%
1,679
+1,441
+605% +$42.8K
RARE icon
1809
Ultragenyx Pharmaceutical
RARE
$2.48B
$52.7K ﹤0.01%
1,753
+1,698
+3,087% +$50.9K
ELAN icon
1810
Elanco Animal Health
ELAN
$13.2B
$52.7K ﹤0.01%
2,616
-1,762
-40% -$29.5K
PRTA icon
1811
Prothena Corp
PRTA
$447M
$52.5K ﹤0.01%
+5,384
New +$41.4K
SNDR icon
1812
Schneider National
SNDR
$6.4B
$52.5K ﹤0.01%
2,480
+1,560
+170% +$38.1K
FDMT icon
1813
4D Molecular Therapeutics
FDMT
$546M
$52.5K ﹤0.01%
+6,038
New +$36.1K
PTC icon
1814
PTC
PTC
$15.1B
$52.4K ﹤0.01%
258
+59
+30% +$12K
EWCZ
1815
DELISTED
European Wax Center
EWCZ
$52.3K ﹤0.01%
+13,113
New +$59.8K
ALC icon
1816
Alcon
ALC
$34.2B
$52.3K ﹤0.01%
701
-227
-24% -$18.9K
FCPT icon
1817
Four Corners Property Trust
FCPT
$2.73B
$52.2K ﹤0.01%
+2,140
New +$55.3K
CVE icon
1818
Cenovus Energy
CVE
$51.5B
$52.2K ﹤0.01%
3,072
+3,045
+11,278% +$47.5K
SFM icon
1819
Sprouts Farmers Market
SFM
$7.98B
$51.9K ﹤0.01%
477
-339
-42% -$49.3K
CRSP icon
1820
CRISPR Therapeutics
CRSP
$5.21B
$51.7K ﹤0.01%
798
+780
+4,333% +$44.8K
MVBF icon
1821
MVB Financial
MVBF
$397M
$51.5K ﹤0.01%
2,056
+1,727
+525% +$41K
GIC icon
1822
Global Industrial
GIC
$1.53B
$51.3K ﹤0.01%
+1,400
New +$47K
CZNC icon
1823
Citizens & Northern Corp
CZNC
$451M
$51.3K ﹤0.01%
+2,591
New +$51K
MD icon
1824
Pediatrix Medical
MD
$2.14B
$51.1K ﹤0.01%
3,050
+2,963
+3,406% +$44.4K
SPXS icon
1825
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$307M
$51K ﹤0.01%
+1,134
New +$48.5K

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.